Chris A. Rhoades

Statistics

Publications

Citations

622

H-Index

Active since

1999

Affiliations

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(Current)

The Ohio State University

The Ohio State University Wexner Medical Center

Chris A. Rhoades is an author at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute specializing in chemotherapy, oncology, and medicine.

Publications per year

1999–2007

Publications

Assessment of Tumor Necrosis Factor Alpha Blockade As an Intervention to Improve Tolerability of Dose-Intensive Chemotherapy in Cancer Patients

J. Paul Monk, G Lewis Phillips, Ross Waite et al. · Journal of Clinical Oncology · 2006 · 179 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients

Bhuvaneswari Ramaswamy, Anthony Elias, Nicole Kelbick et al. · Clinical Cancer Research · 2006 · 121 citations · Full text

Medicine, Oncology, Pharmacology +13

Prospective Evaluation of the Relationship of Patient Age and Paclitaxel Clinical Pharmacology: Cancer and Leukemia Group B (CALGB 9762)

Stuart M. Lichtman, Donna Hollis, Antonius A. Miller et al. · Journal of Clinical Oncology · 2006 · 91 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Disease control, survival, and functional outcome after multimodal treatment for advanced‐stage tongue base cancer

James P. Malone, Julie Stephens, J.C. Grecula et al. · Head & Neck · 2004 · 55 citations

Medicine, Oncology, Surgery +11

Phase I trial of liposomal encapsulated doxorubicin (Myocet™; D-99) and weekly docetaxel in advanced breast cancer patients

Ewa Mrózek, Chris A. Rhoades, Jeffrey C. Allen et al. · Annals of Oncology · 2005 · 31 citations

Pharmacy, Oncology, Pharmacology +17

1–5 of 14